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Abstract 
Background: Aortic prosthetic valve endocarditis (PVE) is a disease with high mortali-
ty, and diagnosis is difficult. Transesophageal echocardiography (TEE) has been the 
mainstay imaging modality in the diagnostic workup, but TEE has diagnostic shortcom-
ings. Thus, new imaging methods might improve the diagnostic workup of PVE.  
 
Aims: I) To investigate the agreement in findings between electrocardiogram (ECG)-
gated computed tomography (CT) and TEE in patients with aortic PVE. II) To identify a 
clinically useful cutoff value for aortic wall thickness to detect PVE. III) To compare 18F-
fluorodeoxyglucose (18F-FDG) uptake around prosthetic aortic valves in patients with and 
without PVE and to determine the diagnostic performance of 18F-FDG PET/CT in the 
diagnosis of PVE. IV) To investigate the value of ECG-gated CT in the surgical decision-
making and preoperative evaluation in patients with aortic PVE.  
 
Methods: In paper I, ECG-gated CT and TEE were compared in a prospective series of 
27 patients with aortic PVE. In paper II, the aortic wall thickness on chest CT in patients 
with a prosthetic aortic valve with PVE (n = 43) and without PVE (n = 260) was com-
pared. In paper III, 18F-FDG uptake on PET/CT in patients with a prosthetic aortic valve 
with PVE (n = 8) and without PVE (n = 19) was compared. In paper IV, 68 aortic pros-
thetic valves with PVE were prospectively evaluated with ECG-gated CT and TEE. The 
impact of both modalities on surgical decision-making was studied, and the coronary 
arteries were evaluated with ECG-gated CT.  
 
Results: In paper I, the strength of agreement [kappa (95 % CI)] between ECG-gated CT 
and TEE was 0.83 (0.62–1.0) for wall thickening, 0.68 (0.40–0.97) for the presence of 
abscess/pseudoanuerysm, 0.75 (0.48–1.0) for valve dehiscence and 0.55 (0.26–0.88) for 
vegetation. In paper II, receiver operating characteristic (ROC) analysis yielded an area 
under the curve of 0.89 for aortic wall thickness in the detection of PVE beyond three 
months postoperatively. With a cutoff value of 5 mm, the sensitivity was 67% and the 
specificity was 95%. In paper III, visual analysis of 18F-FDG PET/CT exhibited a sensitiv-
ity of 75% and a specificity of 84% for the diagnosis of PVE. ROC analysis of the Stand-
ardized Uptake Value ratio yielded an area under the curve of 0.90. In paper IV, 58 of 68 
PVE cases had indications for surgery based on imaging findings. In eight of these cases 
(14%), there was an indication for surgery based on CT but not on TEE findings (all with 
pseudoaneurysms). In 11 cases (19%), there was an indication for surgery based on TEE 
but not on CT findings. In 31 of 32 patients with indication for preoperative coronary 
angiography, ECG-gated CT coronary angiography was diagnostic.  
 
Conclusions: ECG-gated CT provides additional information over TEE regarding para-
valvular extension of infection, which influences surgical decision-making. ECG-gated 
CT can in most cases replace invasive coronary angiography in the preoperative evalua-
tion. Increased aortic wall thickness on CT (> 5mm) beyond three months postoperatively 
is a sign of PVE with high specificity. The level of 18F-FDG uptake in the aortic valve 
area on 18F-FDG PET/CT shows good diagnostic performance in the diagnosis of PVE. 
 
Keywords: prosthetic valve endocarditis, aortic valve endocarditis, ECG-gated CT, 
cardiac CT, 18F-FDG PET/CT 
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Abbreviations 
AVR  aortic valve replacement 
CT   computed tomography 
FDG  fluorodeoxyglucose 
IE   infective endocarditis 
MDCT  multidetector computed tomography 
MRI  magnetic resonance imaging 
NVE   native valve endocarditis 
PET  positron emission tomography 
PVE  prosthetic valve endocarditis 
ROC  receiver operating characteristic 
SPECT single-photon emission computed tomography  
SUV  standardized uptake value 
TEE  transesophageal echocardiography  
TTE  transthoracic echocardiography  
TAVI  transcatheter aortic valve implantation  
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Introduction 
Ancient Egyptian medical practices are some of the oldest that have been docu-
mented and were highly advanced for their time. Several Egyptian medical papy-
ri have been preserved, and one of the oldest is The Ebers Papyrus that dates to 
around 1500 BC. The papyrus describes, maybe for the first time in the history 
of mankind, that the heart is the center of the blood supply, with vessels attached 
for every part of the body [1]. The Greek physicians Hippocrates and Erasistra-
tos both studied at the temple of Amenhotep in Egypt, and they acknowledged 
that the practices of Egyptian medicine had contributed to their own knowledge. 
Erasistratos was the first to describe the valves of the heart around the 3rd centu-
ry BC, although he did not fully understand their function [2]. In the 16th centu-
ry AD, Leonardo da Vinci seems to have understood the function of the cardiac 
cycle and the pulse, and he explained the hemodynamic mechanism of valve 
opening and closure [3].  
 A description of vegetations on the heart valves as a sign of infection was 
first made by the French physician Lazare Rivière in the 17th century [4]. At 
autopsy, he described how “rounded carbuncles…which resembled a cluster of 
hazelnuts…filled up the opening of the aorta” [4]. The condition was named 
endocarditis by another French physician, Jean-Baptiste Bouillaud, in the begin-
ning of the 19th century [5]. The first comprehensive description of endocarditis 
was presented by William Osler, founding professor of Johns Hopkins Hospital, 
in the Gulstonian lectures in 1885 [6]. His lectures drew attention to the disease, 
but there was no effective treatment.  
 The possibility to cure endocarditis first came in the 1940s with the introduc-
tion of penicillin [7]. Antibiotics improved the prognosis but could not cure all 
patients. Twenty years later, in the 1960s, the other cornerstone in the treatment 
of endocarditis was introduced – surgery with valve replacement [8]. This fur-
ther improved the prognosis for endocarditis patients [9]. However, soon after 
the introduction of aortic valve replacement came the first reports of infection in 
a prosthetic heart valve – prosthetic valve endocarditis (PVE) [10]. This condi-
tion proved to be more difficult both to diagnose and to treat than native valve 
endocarditis [11]. With surgery as a therapeutic option, there was a greater need 
for an imaging method that could create a visual representation of the native or 
prosthetic valve and could determine the presence and extension of infection.  
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 The visual representation of the interior of the body became possible after the 
discovery of x-rays in 1895 by Willhelm Conrad Röntgen [12]. There were early 
studies of the heart with x-rays, but it was not possible to visualize the aortic 
valve [12]. Sonar systems were developed for submarines during the Second 
World War, and in the 1960s the same technique was applied to diagnostic imag-
ing with the introduction of medical ultrasound [13]. Ultrasound of the heart 
(echocardiography) was introduced in clinical use in the 1970s, and for the first 
time it was possible to visualize vegetations on the heart valves [14]. With the 
introduction of transesophageal echocardiography (TEE) in the 1980s, the ability 
to detect signs of endocarditis improved [15,16]. However, when a prosthetic 
heart valve is present, the diagnosis of endocarditis remains difficult [17]. TEE 
still has diagnostic shortcomings, and TEE has been reported to be false negative 
in 14–20% of PVE cases [18-20]. 
 Technical improvements have opened up for new diagnostic modalities with 
the potential to improve the diagnostic workup of patients with aortic PVE, and 
this is the subject of this thesis.  
 
 
 
 
 
Figure 1. ECG-gated CT images of a normal aortic valve. A. Transaxial image of the aortic root in diasto-
le shows three symmetric valve leaflets that are closed. B. Three-chamber view of the left ventricle. AO: 
aorta, AV: aortic valve, MV: mitral valve, LV: left ventricle.  	  
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The aortic valve 
The aortic valve is positioned between the left ventricle and the aorta. It is com-
posed of three symmetric leaflets that open when the heart contracts in systole 
and close when the heart relaxes in diastole (Fig. 1). Aortic valve dysfunction 
occurs when the leaflets do not open fully in systole (aortic stenosis) or do not 
close completely in diastole (aortic regurgitation). Aortic stenosis is the most 
common cardiac valve disease [21]. It is an active disease process that is related 
to atherosclerosis and leads to progressive calcifications and reduced motion of 
the leaflets [22,23]. The reduced opening area of the valve induces hemodynam-
ic changes that eventually cause symptoms. Typical initial symptoms are dysp-
nea on exertion and decreased exercise tolerance [24]. Once symptoms occur, 
the prognosis is poor and the only effective treatment is surgery with aortic valve 
replacement (AVR) [24]. The prevalence of aortic stenosis is strongly correlated 
to age with a reported prevalence of 0.2% in the age group 50–60 years increas-
ing to as high as 10% in persons >80 years [25]. 
Aortic regurgitation is less common than stenosis, and moderate/severe re-
gurgitation has a reported prevalence of 0.5% [26]. The most common cause of 
aortic regurgitation in developed countries is bicuspid aortic valve (a congenital 
condition where the aortic valve consists of two leaflets instead of three) [26]. In 
severe symptomatic aortic regurgitation, treatment is surgical [24]. 
 
 
 
 
 
 
Figure 2. Biological prosthetic valve.  
(Courtesy of Edwards Lifesciences)
 
 
Figure 3. Mechanical prosthetic valve. 
(Courtesy of St. Jude Medical) 
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Surgical treatment of aortic valve disease 
The era of surgical treatment of aortic valve disease started with the develop-
ment of cardiopulmonary bypass (the heart-lung machine) in the 1950s, which 
made it possible to operate on a non-beating heart [27]. The first mechanical 
prosthetic valve was implanted in 1960, and the first bioprosthesis in 1965 
[28,29]. Since then, the technique has evolved rapidly and surgical AVR is now 
a routine procedure for treatment of aortic valve dysfunction. AVR is performed 
with cardiopulmonary bypass and during surgery the heart-lung machine tempo-
rarily replaces the pumping action of the heart and the function of the lungs with 
oxygenation of the blood. The aorta is x-clamped and opened, and the diseased 
aortic valve is removed and replaced with a substitute, most often a prosthetic 
valve. The prosthetic valve is sewn into the annulus of the removed native valve. 
 
 
 
Figure 4. Aortic homograft.  
 
 
 
 
 
 
 
 
 
 
The most common valve types are bioprosthetic and mechanical prosthetic 
valves (Figs. 2 and 3). AVR can also be performed with a homograft or with the 
Ross procedure. A homograft (allograft) is an aortic valve that has been removed 
from a human donor (deceased or a heart transplant recipient) and frozen under 
sterile conditions (Fig. 4). A homograft may be used when part of the aortic root 
is destroyed by infection [30]. In the Ross procedure, the aortic valve is replaced 
with the patient’s own pulmonary valve, and the pulmonary valve is replaced by 
a homograft (a pulmonary valve from a human donor) (Fig. 5). Candidates for 
the Ross procedure are children, young adults, and women of child-bearing age 
[31]. There are also different types of valve-sparing surgeries that can be used in 
the case of aortic regurgitation and dilated aortic root [32].  
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The choice of valve type is controversial. In patients with aortic stenosis, cur-
rent guidelines suggest the choice of a bioprosthesis in patients >65 years and a 
mechanical valve in patients <60 years [33]. Mechanical valves are durable but 
require lifelong anticoagulation, which puts the patient at risk of bleeding com-
plications [33]. Bioprosthetic valves have the advantage of better rheologic 
properties and do not require anticoagulation, but they have a limited durability 
[33]. The use of bioprosthetic valves has increased in the last decade due to im-
proved durability, and currently a majority of the patients receive a bioprosthetic 
valve [34]. For patients with comorbidities and who are at too high a risk to un-
dergo cardiac surgery, a new method of replacing the aortic valve in the case of 
aortic stenosis was developed in the early 2000s – transcatheter aortic valve im-
plantation (TAVI) [35]. This valve is placed in the correct position with a cathe-
ter introduced through an artery, usually the femoral artery. There are both self-
expandable and balloon-expandable valves. The stenotic native valve is not re-
moved but is destroyed when the new valve expands. TAVI has been shown to 
be a safe alternative to surgical AVR in high-risk patients [36].  
With increased life expectancy in the population, the mean age of patients re-
ceiving a prosthetic valve has increased and the annual volume of aortic valve 
replacements (both surgical and transcatheter) has increased [34]. All types of 
valve surgery are associated with a risk of prosthetic valve endocarditis (PVE).  
 
 
 
Figure 5. The Ross procedure. The aortic 
valve and aortic root are replaced with a pul-
monary autograft (the patient’s own pulmonary 
valve), and the pulmonary valve is replaced by 
a homograft.  
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Prosthetic valve endocarditis 
Epidemiology  
All four valves of the heart, both native and prosthetic, can be affected by infec-
tive endocarditis (IE) [17]. Left-sided endocarditis (aortic and mitral valve) is 
much more common than right-sided endocarditis (pulmonary and tricuspid 
valve) and accounts for 90–95% of all IE cases [17]. PVE, the most severe form 
of endocarditis, affects the aortic valve in 66–69% of all PVE cases [37,38].  
The reported overall incidence of IE worldwide is about 3–10 cases per 
100,000 people, and in Sweden the incidence is about 6 cases per 100,000 peo-
ple [39,40]. The age of patients with IE has increased substantially over the last 
30 years, and in Sweden the mean age of patients with native valve endocarditis 
(NVE) is 67 years compared to 70 years in PVE patients [41]. With the increas-
ing prevalence of prosthetic heart valves and intra-cardiac devices in the popula-
tion, the incidence of PVE is rising and PVE accounts for 20–30% of 
endocarditis cases today [42,43]. The presence of a prosthetic valve increases the 
risk of endocarditis 50 times compared with the general population. The reported 
incidence of PVE worldwide is 0.3–1.2%, and in Sweden it is 0.4% [24,39]. Re-
ports on PVE after TAVI is limited, but a recently published multicenter registry 
study reported an incidence of 0.67% [44].  
Etiology and pathophysiology 
IE is an infection of the inner layer of the heart, the endocardium. The healthy 
endothelium is resistant to bacteria, but when the endothelium is damaged a 
platelet-fibrin thrombus forms that makes it easier for bacteria to adhere to the 
surface [45]. Endothelial damage and bacteremia (the presence of bacteria in the 
blood) are the two most important factors in the pathophysiology of IE [11]. En-
dothelial damage can be caused by congenital or degenerative valve changes, 
inflammation, or injury from catheters and electrodes [11]. Bacteremia with oral 
pathogens is seen during invasive procedures such as dental extraction, but tran-
sient bacteremia is also common with everyday activities such as chewing and 
tooth brushing [11].  
 The underlying heart conditions of IE have changed in recent years, especial-
ly in developed countries. Rheumatic disease, which used to be a common cause 
and still is in developing countries, is rarely seen in the Western world [11,24]. 
IE is now more often associated with degenerative valve changes, intravenous 
drug abuse, prosthetic heart valves, and intra-cardiac devices [11,46]. The intro-
duction of foreign material, e.g. a prosthetic valve, into the body results in an 
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increased risk of infection at the implant site. Bacteria or other microorganisms 
can be introduced perioperatively at the implant site or can be blood-borne dur-
ing later episodes of bacteremia [47].  
Microbiology 
Both community-acquired and health care-associated Staphylococcus aureus 
bacteremia is increasing worldwide [46,48], and today S. aureus is reported as 
the most common cause of IE in many studies [49,50] and accounts for around 
30% of all episodes [43,46]. Other common pathogens are oral streptococci from 
the viridans group, enterococci, and coagulase-negative staphylococci [40,46]. 
The causative pathogens differ in NVE and PVE with coagulase-negative staph-
ylococci, gram-negative bacteria and fungi being more common in PVE [17]. 
The etiological spectrum also varies between early and late PVE; in late PVE the 
bacterial etiology resembles what is seen in NVE [38,47]. Staphylococcal endo-
carditis is associated with an increased risk of in-hospital death, whereas endo-
carditis caused by viridans streptococci is associated with a lower risk [46].  
Symptoms 
Clinical presentation of IE can be non-specific, and the diagnosis is often missed 
or is initially uncertain. The most common presenting symptom is fever, which 
is seen in more than 90% of the patients [11]. Fever in combination with risk 
factors such as prosthetic valve, intracardiac device, valvular disease, congenital 
heart disease, or intravenous drug abuse should lead to the suspicion of endocar-
ditis. Presenting symptoms in IE can also be caused by a complication such as a 
cerebral or systemic embolic event, which is seen in 20–40% of the patients 
[40,46,51]. Other symptoms are immunological phenomena such as splinter 
hemorrhages under the nails, retinal hemorrhages (Roth spots) and glomerulone-
phritis [11]. An atypical presentation with non-specific symptoms and the ab-
sence of fever is more common in elderly patients and also in PVE [52]. In the 
postoperative period after valve replacement, fever is also common in the ab-
sence of PVE, which leads to a diagnostic dilemma in such a situation [17].  
Diagnostic workup 
IE is a diagnosis based on multiple objective findings that also takes into account 
specific risk factors associated with the disease. Positive blood cultures and signs 
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of endocardial involvement on echocardiography are cornerstones of the diagno-
sis. In 1994, Durack et al presented criteria for the diagnosis of endocarditis that 
are referred to as the Duke criteria [53]. Based on blood cultures and echocardi-
ographic and clinical signs, the diagnosis was classified as definite, possible or 
rejected endocarditis. The criteria were criticized because a large proportion of 
patients received the diagnosis “possible endocarditis” [54], and this led to a 
modification of the Duke criteria in 2000 [55]. The modified criteria have been 
used ever since (Table 1).  
 
 
Table 1: Modified Duke criteria for the diagnosis of infective endocarditis 
Major criteria 
-blood culture positive for endocarditis 
• typical microorganisms consistent with IE from two separate blood cultures or 
• microorganisms consistent with IE from persistently positive blood cultures or 
• single positive blood culture for Coxiella burnetii or phase I IgG antibody titer >1:800 
-evidence of endocardial involvement 
• echocardiography positive for IE  
• new valvular regurgitation 
 
Minor criteria 
-predisposition predisposing heart condition, drug use 
-fever temperature >38°C 
-vascular phenomena major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, 
intracranial hemorrhage, conjunctival hemorrhage, Janeway lesions 
-immunologic phenomena glomerulonephritis, Osler’s nodes, Roth’s spots, rheumatoid factor 
-microbiological evidence positive blood culture but does not meet a major criterion or serological 
evidence of active infection with an organism consistent with IE 
 
Definite endocarditis 
-2 major criteria or 
-1 major and 3 minor or 
-5 minor 
 
Possible endocarditis 
-1 major and 1 minor or 
-3 minor 
 
IE = infective endocarditis. Adapted from Li et al [55]. 
 
In NVE, the criteria have a reported sensitivity of 70–80% [17]. However, in the 
presence of a prosthetic valve, the modified Duke criteria have a lower sensitivi-
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ty, mainly due to the lower diagnostic accuracy of echocardiography in PVE 
[17]. In the modified Duke criteria, specific echocardiographic findings are ma-
jor criteria in the diagnosis of endocarditis [56]. The first-line imaging method is 
transthoracic echocardiography (TTE), but TEE is a more sensitive method and 
is recommended in all patients with a prosthetic heart valve or intracardiac de-
vice and in patients with suspicion of NVE when TTE is negative [17].  
 Three echocardiographic findings constitute major criteria in the diagnosis of 
endocarditis: vegetation, abscess/pseudoaneurysm, and new dehiscence of a 
prosthetic valve. Vegetations are masses containing bacteria, platelets, and fibrin 
that adhere to the valve leaflets, and this is the most common finding in NVE 
[46]. In PVE, the infection more often affects the valve ring and extends into the 
aortic wall and the perivalvular myocardium. Abscess cavities might form adja-
cent to the valve ring, and when an abscess cavity drains into the aorta or the left 
ventricle a pseudoaneurysm is formed [57]. Tissue destruction can lead to partial 
detachment of the prosthetic valve ring from the aortic wall resulting in valve 
dehiscence with perivalvular regurgitation of blood. Perivalvular extension of 
infection has been reported in 14–39% of NVE cases [46,58,59] and in 30–60% 
of PVE cases [38,58,59]. The data on PVE in TAVI patients are limited, but in a 
multicenter registry study of 53 TAVI PVE cases, vegetation was the most 
common imaging finding (77%) and perivalvular abscess/pseudoaneurysm for-
mation was seen in 18% of the patients [44]. 
 The sensitivity of TEE for detection of endocarditis is lower in PVE than in 
NVE [60], and TEE has been reported to be false negative in 14–20% of PVE 
cases [18-20].  
Treatment 
Microbial eradication with antimicrobial drugs and surgical removal of all in-
fected material are the two major components in the treatment of IE. Medical 
therapy with antimicrobial drugs is used in all cases. In PVE patients, a treatment 
period of a minimum of six weeks is recommended [17]. In many cases, surgical 
treatment is also required to eradicate the infection and to replace a dysfunction-
al valve. Indications for surgery follow the same principles in NVE and PVE. 
The main indications for surgery are heart failure, uncontrolled infection, and the 
prevention of embolic events [17]. The decision for surgery should be individu-
alized and discussed in a multidisciplinary team considering both comorbidities 
and risks associated with surgery and the prospect of recovery without surgery 
[17].  
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In PVE patients, uncontrolled infection is in most cases caused by perivalvular 
extension of the infection, which is associated with poor prognosis and high like-
lihood of a need for surgery (Fig. 6) [11]. Around 50% of patients with PVE 
undergo surgical therapy [38,61]. The type of surgery performed is individually 
tailored and depends on the extension of infection. The most common indication 
for surgery in PVE patients is perivalvular extension of infection and in this case 
the use of a homograft is favorable [62]. The infected valve and all necrotic and 
infected tissue around the valve are removed, and a homograft is implanted. 
When the infection is limited to the valve leaflets with no perivalvular destruc-
tion, a bioprosthesis or a mechanical valve can be used. In Gothenburg, 64% of 
aortic PVE patients over the last 20 years received a homograft [63]. 
 
 
 
 
 
 
Figure 6. Surgery for PVE in a patient with a 
mechanical prosthetic valve. The aorta was 
transected, and the valve was exposed.  The 
prosthetic valve was dehisced in 2/3 of the 
circumference and was excised only in the 
area seen to the left in the figure.   
 
 
 
 
 
 
 
 
 
Prognosis 
PVE is the most severe form of endocarditis with a reported in-hospital mortality 
of 20–40% [17,38,64]. The corresponding figures for NVE are 15–30% [17]. 
Heart failure, perivalvular complications, and S. aureus infection are factors as-
sociated with increased risk of death, and when all three factors are present the 
risk reaches 79% [65].  
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Imaging of the heart valves 
Imaging of the heart is challenging because the structures are small and they 
move continuously during the cardiac cycle. This means that both high spatial 
and temporal resolution are required to visualize the heart and heart valves. In 
most cases, echocardiography is the first choice when valve disease is suspected. 
Cardiac computed tomography (CT) and 18F-fluorodeoxyglucose positron emiss-
ion tomography/computed tomography (18F-FDG PET/CT) may provide addi-
tional information regarding valve pathology and metabolic activity. 
Echocardiography 
History 
High-frequency ultrasonic systems were developed late in the Second World 
War by the US Navy to navigate submarines. Shortly after the war, the American 
physician John Wild had the idea to use ultrasound for detecting changes of tex-
ture in living tissues, and the era of medical ultrasound began [66]. One of the 
first reports of using ultrasound to study heart movements came from the physi-
cian Inge Edler and the electrotechnician Hellmuth Hertz in Lund, Sweden, in 
1954 [67]. The use of ultrasound for examination of the heart was named echo-
cardiography, and the method has been in widespread clinical use since the 
1970s. With the transducer placed on the thoracic cage, the method is called 
TTE. In the 1980s, TEE was introduced in which the examination is performed 
with the transducer placed in the esophagus [68]. With this method, the trans-
ducer comes closer to the dorsal side of the heart, and TEE is superior to TTE in 
depicting the heart valves, aorta, and atria (Fig. 7). In the same decade, color 
flow Doppler imaging was developed as a technique to detect valvular regurgita-
tion [69]. The most recent improvement in echocardiography technique is three-
dimensional echocardiography [70], which can provide 3D images of the heart 
valves.  
 At Sahlgrenska University Hospital, echocardiography has been in use since 
the late 1970s, and currently around 10,000 clinical echocardiography examina-
tions are performed annually at the Department of Clinical Physiology.  
Technical aspects 
The sound waves used in clinical ultrasound have a frequency of 1–20 MHz, 
which are not audible to the human ear [71]. Pulses of ultrasound waves are sent 
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into the body tissue from a transducer placed on the chest wall or in the esopha-
gus. Different tissues reflect the sound to a varying degree, and the reflected 
sound echoes are recorded by the transducer and displayed as an image. The 
temporal resolution of echocardiography is excellent and goes down to 20 ms, 
which means that 50 images per second are displayed. Doppler echocardiog-
raphy uses the Doppler effect to determine whether blood is moving towards or 
away from the transducer [72]. Both the direction and the speed of the blood 
flow can be studied, and this method is particularly useful for studying valve 
function. 
 
 
 
 
Figure 7. TEE images of a normal biological prosthetic valve. A. Long axis projection in systole. The 
asterisk marks acoustic shadowing from the prosthetic valve. B. Short axis projection in diastole. The 
asterisks indicate artifacts adjacent to the right coronary cusp. NC: non-coronary cusp, LC: left coronary 
cusp, RC: right coronary cusp. 
Risks and costs 
TTE is a safe and non-invasive imaging method, and ultrasound has no known 
risks or complications to the patient. When TEE is performed, a probe is intro-
duced into the esophagus, which means a small risk of injury to the esophagus, 
bronchospasm, or cardiac arrhythmias [73]. The reported complication rate for 
TEE is 0.18% [73]. A TTE examination currently costs around 3500 SEK at 
Sahlgrenska University Hospital, and a TEE examination costs around 4200 
SEK.  
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Clinical use 
Medical ultrasound is used in imaging of all parts of the body. Major areas of 
use are abdominal (liver, gall bladder and kidneys), gynecological, vascular, and 
cardiac imaging. Echocardiography is an easily accessible cardiac imaging 
method that is performed on most patients where cardiac disease is suspected. 
Heart valve imaging with echocardiography 
Echocardiography is the first-line imaging method in the workup of patients with 
valvular heart disease [24]. It depicts both the morphology and the motion of the 
cardiac valves and can in most cases determine the etiology of valvular heart 
disease. It is also used for the monitoring and follow-up of patients with known 
valvular heart disease [24]. TEE is recommended in patients with suspicion of 
cardiac source of embolism, for evaluation of the aortic and mitral valve, and for 
prosthetic heart valve evaluation [74]. In patients with suspicion of endocarditis, 
TEE is recommended in most cases and is mandatory in the presence of a pros-
thetic heart valve [17].  
Cardiac Computed Tomography 
History 
A CT scanner consists of an x-ray tube that rotates around the patient, and imag-
es are taken from different angles and are combined in the computer to produce 
cross-sectional images of the body. The first generation of CT scanners was in-
troduced in 1972 [75], an invention that earned Godfrey Hounsfield and Allan 
Cormack the Nobel Prize in Medicine in 1979. The scanner was used for brain 
imaging only, and the examination was time-consuming because the scanning of 
one cross-sectional image took about five minutes. The first report of cardiac 
imaging with CT is from 1981 [76]. The CT scanner used had a rotation time of 
two seconds, yielding a temporal resolution of one second, and motion-free im-
ages could not be acquired.  
 In the 1980s, the electron-beam CT scanner was introduced, and this scanner 
was constructed for cardiac imaging where both the detector and the source were 
stationary. The first electron-beam CT scanners had an improved temporal reso-
lution of 100 ms. In combination with the introduction of electrocardiogram 
(ECG)-gating of the scan (see below), motion-free images of the heart in diastole 
could be acquired [77]. However, the spatial resolution remained a problem. In 
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1989, slip-ring technology was introduced with the first helical CT scanner, an 
invention that improved the spatial resolution [78]. In helical scanning (also 
named spiral CT), the patient moves continuously through the scanner while the 
gantry rotates. The technique was further improved with the introduction of mul-
tiple detector rows in the 1990s, known as multidetector CT (MDCT) [79], 
which allows simultaneous acquisition of multiple slices per gantry rotation. 
Since the 1990s, this technique has been rapidly evolving with an ever-
increasing number of detector rows (currently up to 320) and faster rotation 
times. In the latest generation of CT scanners, the temporal resolution is as low 
as 66 ms with a spatial resolution of 0.24 mm. These technical advances, in 
combination with software development, have made high-resolution and motion-
free imaging of the heart possible.  
 At Sahlgrenska University Hospital, the first 64-slice CT scanner was in-
stalled in 2005 and had a temporal resolution of 175 ms and a spatial resolution 
of 0.625 mm and was suitable for cardiac imaging. This was the first scanner 
used for cardiac CT studies in this thesis. 
Technical aspects 
Other names used in the literature for cardiac CT are ECG-gated CT of the heart 
and MDCT of the heart. The basic principle of cardiac CT is synchronization of 
data acquisition to the patient’s ECG. The key to successful imaging is a slow 
and regular heart rhythm, and, if possible, a beta-blocker is administered before 
the examination to lower the heart rate. The examination is performed with intra-
venous contrast administration to enhance the vessels and cardiac chambers. 
 There are two basic acquisition principles, retrospective and prospective 
ECG-gating. In retrospective ECG-gating, CT scanning is performed in a helical 
mode with continuous data collection during the entire cardiac cycle. After-
wards, the ECG record is used to select data that have been acquired during the 
same phase of the cardiac cycle, and image stacks can be reconstructed at any 
cardiac phase. For example, the cardiac cycle can be split into 10 equal phases, 
which means that 10 image stacks of the heart will be reconstructed. These im-
age stacks can be used to create moving images (cine films) of the heart.  
 In prospective ECG-gating, CT scanning is performed in axial mode (the 
table is at a fixed position while the gantry rotates) at a pre-defined phase of the 
cardiac cycle. To acquire motion-free images of the heart, imaging is usually 
best performed in diastole. Because the duration of diastole is long with slow 
heart rates and decreases with faster heart rates, a slow heart rate is preferable. 
The drawback of prospective ECG-gating is that cardiac function cannot be as-
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sessed because images are created in a single phase of the cardiac cycle. The 
advantage is a lower radiation dose.  
 The technique of prospective ECG-gating has improved, and this method is 
currently the first choice for imaging of the coronary arteries because of the low-
er radiation dose. When the heart rhythm is high or variable, retrospective gating 
should be used. Retrospective gating is also the method of choice for valve im-
aging because it gives the possibility to study the movement of the valve with 
cine films. 
 
 
 
 
Figure 8. ECG-gated CT of a stenotic aortic valve performed prior to TAVI. The images are used to 
measure the dimensions of the aortic valve annulus and its relation to the coronary arteries. The infor-
mation is then used for planning the TAVI procedure and selecting the right size of the valve prosthesis. 
A. Transaxial image of the aortic valve shows calcified valve leaflets. Cine imaging showed reduced 
opening area of the valve. B. Three-chamber view of the left ventricle. A post-stenotic dilatation of the 
ascending aorta is seen. AO: aorta, LV: left ventricle, LA: left atrium.  
Risks and costs 
Cardiac CT is an x-ray technique, which means that the patient is exposed to 
ionizing radiation. Radiation doses from cardiac CT are getting lower with new 
generations of scanners, and the latest scanners can perform a cardiac CT scan 
with a dose of around 1 millisievert (mSv) under optimal conditions [80]. Retro-
spective ECG-gating, which is the method used when the cardiac valves are 
studied, still means higher radiation doses [81]. The mean radiation dose for the 
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cardiac CT examinations performed in this thesis was around 10 mSv, which is 
ten times the yearly natural background radiation in Sweden.  
 Another risk with cardiac CT is the administration of intravenous contrast 
medium. In patients with impaired renal function, the contrast medium implies a 
risk for contrast-induced nephropathy and should be used with caution [82]. The 
contrast medium can also cause allergic reactions including anaphylaxis [83]. An 
ECG-gated cardiac CT examination currently costs around 5700 SEK at 
Sahlgrenska University Hospital.  
Clinical use 
The main use of cardiac CT is imaging of the coronary arteries. The negative 
predictive value of cardiac CT is very high, which means that the method can be 
used to rule out coronary artery stenosis [84]. Current European guidelines state 
that cardiac CT can be used to rule out stable coronary artery disease in patients 
with intermediate pre-test probability [85]. Other common clinical applications 
include evaluation of the anatomy of the pulmonary veins before pulmonary vein 
ablation, assessment of congenital heart disease, and assessment of the pericar-
dium [86].  
Heart valve imaging with cardiac CT 
Valve imaging with cardiac CT started in the beginning of the 21st century with 
the description of aortic valve morphology in patients with aortic stenosis [87]. 
Since then, the method has become a clinical standard for the evaluation of valve 
morphology and aortic root dimensions prior to TAVI (Fig. 8) [88]. Other clini-
cal applications include imaging of congenital valve disease [89] and valve tu-
mors [90]. In patients with a prosthetic heart valve, cardiac CT has been used to 
detect thrombosis and pannus formation on the valve leaflets [91] and to depict 
valve degeneration [92]. In 2009, Feuchtner et al studied valvular abnormalities 
in patients with IE on cardiac CT and compared the findings with TEE and sur-
gery [93]. The results were promising and suggested that cardiac CT might have 
a role in the workup of patients with IE. A few case reports have demonstrated 
that CT might also have a role in diagnosing PVE in patients with a TAVI valve, 
but no larger studies have been published on this group of patients [94,95]. 	  
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18F-FDG PET/CT 
History 
PET/CT is the youngest of the imaging methods discussed in this thesis. The 
method was developed in the 1990s, and the first commercial PET/CT scanner 
was introduced in 2001 [96]. At Sahlgrenska University Hospital, the first 
PET/CT scanner was installed in 2008. To date, the radiopharmaceuticals used 
are produced in Lund and transported in a taxi to Gothenburg. A cyclotron will 
be installed at Sahlgrenska University Hospital in 2016, and the production of 
radiopharmaceuticals for clinical use will start in 2017.  
Technical aspects 
PET/CT is a combined anatomical and functional imaging method where a CT 
scanner and a PET scanner are combined in a single gantry. The PET scanner 
detects gamma rays that are emitted from a positron-emitting radionuclide that is 
injected intravenously into the patient. The CT scanner provides anatomical in-
formation, and when the two separately recorded images are fused an image con-
taining both anatomical and functional information is produced (Fig. 9). 
 
 
 
Figure 9. 18F-FDG PET/CT in a patient with an infected composite graft in the ascending aorta. Transax-
ial images through the mid-thorax at the level of the bifurcation of the pulmonary artery. The images 
show increased 18F-FDG uptake around the graft indicating infection. A. Low dose CT. B. 18F-FDG PET. 
C. Fused 18F-FDG PET/CT. 
 
 
The most common radiopharmaceutical used in PET/CT imaging is the glucose 
analogue 18F-FDG. The radionuclide 18F is synthetized in a cyclotron and then 
incorporated in the glucose molecule yielding 18F-FDG. When injected into the 
body, this radiopharmaceutical distributes according to the tissue cell uptake of 
glucose. FDG cannot be further metabolized in the cells. After the injection, the 
patient rests for an hour while the glucose analogue distributes throughout the 
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body. Muscle activity should be minimized during this period because active 
muscles metabolize glucose, which can cause artifacts. After 60 minutes of rest, 
the scanning is performed, which takes about 15 minutes. 
 Risks and costs 
18F-FDG PET/CT, like cardiac CT, means that the patient is exposed to ionizing 
radiation. When 18F-FDG PET/CT is performed, radiation comes both from the 
injected radioactive tracer that is distributed throughout the body and from the 
low-dose CT scan. The current total radiation dose for a PET/CT scan at 
Sahlgrenska University Hospital is around 8 mSv, including 5 mSv from the 
radioactive tracer [for a 70 kg person (4 MBq/kg)] and 3 mSv from the low-dose 
CT scan. An 18F-FDG PET/CT examination costs around 18,000 SEK.  
Clinical use 
18F-FDG is taken up by cells that are using glucose for their metabolism, which 
yields a high activity in tissues with high glucose uptake such as the brain, heart, 
and liver. Most malignant tumors also have a high glucose uptake, and the cur-
rent main clinical application for 18F-FDG PET/CT is oncological imaging. 18F-
FDG PET/CT is used in the diagnosis, staging, and evaluation of treatment re-
sponse of many cancer forms such as lung cancer, head and neck cancer, lym-
phoma, and malignant melanoma and in the workup of cancer of unknown origin 
[97-100].  
18F-FDG PET/CT in the imaging of infection 
Cells involved in the inflammatory process have a high glucose uptake, and there 
is an increasing interest in using 18F-FDG PET/CT to identify infectious process-
es [101,102]. 18F-FDG PET/CT has been used in the diagnosis of osteomyelitis 
[103] and spondylodiscitis [104]  and in cases of fever with unknown origin 
[105]. Initially, doubts were raised about the ability to detect infectious processes 
close to the heart due to the physiological FDG uptake in the cardiac muscle 
[106]. This can be overcome with a low carbohydrate and high fat diet – which 
elevates the level of free fatty acids in the blood and introduces fat-dominated 
metabolism – followed by an 18-hour fasting period prior to the examination. 
The procedure reduces the physiological accumulation of 18F-FDG in the myo-
cardium [107].  
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 The first reports of 18F-FDG PET/CT imaging in endocarditis considered 
detection of metastatic infection/septic emboli [106]. The first study on 18F-FDG 
PET/CT in the diagnosis of endocarditis came in 2013 [108]. This study showed 
a sensitivity of 39% and a specificity of 93% for the diagnosis of endocarditis 
[108]. All but two valves studied were native. The first study on prosthetic 
valves came the same year and found a sensitivity of 73% and a specificity of 
80% for the diagnosis of PVE [109]. The authors suggested that 18F-FDG 
PET/CT could be added to the diagnostic criteria for PVE, thus reducing the 
number of “possible” PVE cases [109]. 	  
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Aims 
General aim 
The aim of this thesis was to investigate the value of ECG-gated CT and 18F-
FDG PET/CT in the diagnostic workup of aortic PVE. 
Specific aims 
I. To investigate the agreement in findings between ECG- gated CT and 
TEE in patients with aortic PVE. 
 
II. To identify a clinically useful cutoff value for aortic wall thickness to de-
tect PVE. 
 
III. To compare 18F-FDG uptake around prosthetic aortic valves in patients 
with and without PVE and to determine the diagnostic performance of 18F-
FDG PET/CT in the diagnosis of PVE. 
 
IV. To investigate the value of ECG-gated CT in the surgical decision-making 
and preoperative evaluation in patients with aortic PVE. 	  
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Patients and Methods  
Paper I and paper IV present results from a prospective study where the Regional 
Ethics Review Board gave ethical approval and informed consent was obtained 
from all patients. 
Paper II and paper III are retrospective studies where the Regional Ethics Re-
view Board waived the need for informed consent. 
 
 
 
 
 
 
Figure 10. Flowchart of included patients in all four papers. *CT not performed (n = 4), TEE not per-
formed (n = 1), neither CT nor TEE performed (n = 1), case missed in study inclusion (n = 1); **one CT 
examination was performed before 2008. 
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Patients 
Recruitment of PVE patients for all four papers is shown in Fig. 10.  
Paper I 
Twenty-seven consecutive patients with PVE underwent ECG-gated CT and 
TEE, and the results were compared. Imaging was compared with surgical find-
ings. 
Paper II 
CT studies performed on a CT scanner with at least 16 slices on patients with a 
prosthetic aortic valve were retrospectively analyzed. The aortic wall thickness 
in patients with definite PVE (n = 43) was compared to the aortic wall thickness 
in patients without PVE (n = 260).  
Paper III 
18F-FDG-uptake on 18F-FDG PET/CT around prosthetic aortic valves in patients 
with PVE (n = 8) and without PVE (n = 19) was compared. 18F-FDG PET/CT 
examinations in the PVE group were performed between 2013 and 2014 in clini-
cal practice when results from routine clinical workup were inconclusive regard-
ing the diagnosis or the extension of the infection. The controls had undergone 
an 18F-FDG PET/CT examination between 2008 and 2014, and the indication for 
the examination was suspicion of malignancy or staging/treatment control of 
malignancy. 
Paper IV 
Sixty-eight prosthetic valves in 67 patients with aortic PVE were prospectively 
evaluated with ECG-gated CT and TEE. Indication for surgery based on imaging 
findings from ECG-gated CT and TEE was evaluated. Imaging findings consid-
ered as indications for surgery were 1) abscess/pseudoaneurysm formation, 2) 
prosthetic valve dehiscence, 3) valve destruction with valvular regurgitation, and 
4) large vegetations (>1.5 cm). The coronary arteries were evaluated with ECG-
gated CT. Clinical data including surgical reports and mortality data, were col-
lected. 
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Imaging protocols and analysis 
ECG-gated CT protocol (papers I and IV) 
The protocol for ECG-gated CT in the prospective study has been described in 
detail in paper I. The examination started with a scan of the thorax without con-
trast medium. This scan was used to plan the contrast-enhanced ECG-gated CT 
scan but also to identify surgical material in the aortic root that could be mistak-
en for contrast (Fig. 11). The contrast-enhanced ECG-gated scan was performed 
with a retrospective technique to enable cine imaging of the valve.  
 
 
Figure 11. A. Contrast-enhanced ECG-gated CT scan shows a rounded structure (arrow) between the 
aorta and the pulmonary artery with attenuation similar to the contrast-enhanced blood. A small pseudo-
aneurysm may be suspected. B. The CT scan performed before contrast administration shows that the 
structure represents surgical material (arrow).  
18F-FDG PET/CT protocol (paper III) 
The preparation for the PET/CT examination was different in the group with 
suspected PVE compared to the control group. Patients in the control group fol-
lowed the standard preparation and fasted for 6 hours prior to PET/CT. In pa-
tients with suspected PVE, reduction of the physiological uptake of 18F-FDG in 
the myocardium is desirable. To achieve this, the patients were requested to have 
a meal rich in fat and low in carbohydrates and then to fast for at least 18 hours 
A B 
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prior to the examination [107]. The PET/CT scan was performed when the pa-
tient had rested for 60 minutes after 18F-FDG-injection in both groups. In pa-
tients with suspected PVE, only the thorax was scanned, and in the control group 
the scan area varied depending on the indication for the examination.  
Image analysis – paper I and IV 
In paper I and IV, image analyses of the ECG-gated CT and TEE examinations 
were performed by physicians blinded to the results of the other examination but 
with knowledge of the clinical history of the patient. The findings studied are 
summarized in Table 2, and CT findings are exemplified in Fig. 12. Imaging 
findings suggesting endocarditis were based on guidelines [11].  
 
 
Table 2: Imaging findings indicating PVE 
Finding Imaging characteristics 
Vegetation Oscillating or non-oscillating mass attached to 
the valve 
Abscess Low-echogenic/attenuating perivalvular cavity 
that does not communicate with the aorta or 
the left ventricle 
Pseudoaneurysm Perivalvular cavity communicating with the 
aorta or left ventricle 
Valve dehiscence New perivalvular regurgitation with or without a 
rocking motion of the prosthesis 
Increased aortic wall thickness Aortic wall thickness of >5 mm measured per-
pendicular to the wall where the aorta is ap-
posed to the left atrium 
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Image analysis – paper II 
The wall thickness of the aortic root was measured in a standardized procedure 
in the dorsal aspect of the aortic root where the aorta is apposed to the left atrium 
(Fig. 12B). To assess inter-observer variability, a second radiologist inde-
pendently analyzed 40 studies. To assess intra-observer variability, 40 studies 
were re-analyzed by the first radiologist 6 months after the first evaluation. 
 
 
 
Figure 12. ECG-gated CT images with findings indicating PVE. A: Vegetation (arrow) on a biological 
prosthesis. B: Increased aortic wall thickness measured between the aorta and the left atrium perpendic-
ular to the wall (arrow). C: Pseudoaneurysm (arrow) communicating with the left ventricular outflow tract.  
Image analysis – paper III (18F-FDG PET/CT) 
Before analysis, all examinations were anonymized and cropped to include only 
the thorax. Two nuclear medicine physicians independently performed both vis-
ual analysis and semi-quantitative analysis. On visual analysis, a positive result 
was defined as focal areas of increased uptake of 18F-FDG in the prosthetic valve 
area, and the uptake was confirmed on non-attenuation-corrected images. Semi-
quantitative analysis was performed by measuring the maximal standardized 
uptake value (SUVmax) in the valve region. To adjust for background uptake, the 
valve SUVmax was divided by SUVmax in the descending aorta to give SUVratio. 	  
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Statistical analysis 
Kappa statistics (paper I) 
In the prospective study presented in paper I and IV, only patients with high sus-
picion of PVE were studied. Because the majority of the patients received the 
final diagnosis of PVE and the diagnosis was based partly on findings from the 
study examinations, we did not consider calculation of sensitivity and specificity 
to be meaningful. Instead, our choice in paper I was to present the results in 
crosstabs and to calculate the Cohen’s kappa as a measurement of agreement 
between CT and TEE. With this statistical approach, neither of the methods is 
considered the gold standard, and the method instead describes the strength of 
agreement between the two methods. A kappa value of 0.41–0.60 is considered 
moderate agreement, 0.61–0.80 good agreement, and 0.81–1.0 very good agree-
ment. The drawback of this method is that it does not describe the additive value 
of the new method (CT) compared to the old method (TEE).  
 
 
 
 
 
Figure 13. Example of a ROC curve. Each point on the curve represents a cutoff value. The area under 
the ROC curve quantifies the ability of the test to discriminate between individuals with and without dis-
ease. Increasing the cutoff value means moving to the left on the ROC curve, which increases specificity 
at the cost of lower sensitivity.  	  
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ROC analysis (paper II and III) 
In paper II, the aortic wall thickness in PVE patients and controls was compared. 
In paper III, SUVmax and SUVratio in PVE patients and controls were compared. 
The Mann–Whitney U-test was used to compare groups. However, a significant 
difference between the two groups does not necessarily mean that the diagnostic 
test is useful. To determine the diagnostic performance for detection of PVE, 
receiver operating characteristic (ROC) analysis was performed [110]. A ROC 
curve is produced by plotting the true positive rate (sensitivity) against the false 
positive rate (1 – specificity) for all cutoff values (Fig. 13). The area under the 
curve is a measure of how well the test can distinguish between the two groups 
(PVE/non-PVE), where an area of 1 represents a perfect test. The curve can also 
be used to select the optimal cutoff value for the diagnostic test. An optimal cut-
off value should be situated near the upper left corner of the ROC curve.  
Likelihood ratios (paper II and III) 
The ROC analysis is used to select a cutoff value with the desired balance be-
tween sensitivity and specificity. Once the cutoff value has been selected, likeli-
hood ratios can be calculated. The likelihood ratios describe how the probability 
of having disease changes if the test is positive or negative [111]. The positive 
and negative likelihood ratios (LR(+) and LR(–)) are calculated as: LR(+) = sen-
sitivity / (1 – specificity) and LR(–) = (1 – sensitivity)/specificity. A positive 
likelihood ratio >10 or a negative likelihood ratio <0.1 corresponds to a large 
increase or decrease in the likelihood of disease, respectively (this is a very in-
formative test). The post-test odds for a patient to have the disease can be calcu-
lated by multiplying the pre-test odds by the likelihood ratio.  	 	
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Results 
Paper I 
Twenty-seven consecutive patients with aortic PVE were investigated with 
ECG-gated CT and TEE. All 27 patients had definite PVE according to the mod-
ified Duke criteria [55]. TEE suggested the presence of PVE in all 27 patients, 
and ECG-gated CT suggested the presence of PVE in 25 of these patients. A 
comparison between the two methods with kappa statistics is shown in Fig. 14. 
 
 
 
Figure 14. The distribution of positive and negative findings on CT and TEE. The quantification of 
agreement was performed using kappa statistics. 
 
 
Sixteen out of 27 patients underwent surgery, and the strength of agreement was 
good between surgery and ECG-gated CT (kappa = 0.66) and TEE (kappa = 
0.79). When the findings from ECG-gated CT and TEE were combined, the 
strength of agreement with surgery was very good (kappa = 0.88) (Fig. 15). 
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Figure 15. Crosstabs show the distribution of positive and negative findings for ECG-gated CT (left), 
TEE (middle) and the combination of TEE and ECG-gated CT (right) versus surgery. Positive findings 
are vegetation, abscess/pseudoaneurysm and dehiscence. The quantification of agreement was per-
formed using kappa statistics. 
Paper II 
The study included 260 CT studies in patients (n = 185) without PVE and 43 CT 
studies in patients (n = 43) with definite PVE. In non-PVE patients, the wall 
thickness was increased in the early postoperative period with large dispersion 
(Fig. 16). After three months, the wall thickness had decreased and stabilized, 
and the 95th percentile was at 5 mm. 
 
 
 
Figure 16. Aortic wall thickness in non-PVE patients for the first two years postoperatively. The wall 
thickness is increased in the early postoperative period. 
 
21	 2	1	 24	
Kappa	0.88	
(95%	CI	0.74-1.0)	
CT
	
Surgery	
Kappa	0.66	
(95%	CI	0.49-0.87)	
16	 2	6	 24	
Neg	Pos	 Pos	Neg	 TEE	
Surgery	
Kappa	0.79	
(95%	CI	0.62-0.96)	
19	 2	3	 24	
Neg	Pos	 Pos	Neg	 CT+TEE
	
Surgery	Neg	Pos	 Pos	Neg	
  
Results 41	
 
 
The aortic wall thickness in PVE patients (<3 months = 6.6 ± 2.4 mm, >3 
months = 6.9 ± 3.6 mm) was significantly increased compared to non-PVE pa-
tients (<3 months = 4.5 ± 1.7 mm, >3 months = 3.2 ± 1.0 mm) both when com-
pared for the first three months postoperatively and beyond three months 
postoperatively (p = 0.012 and p < 0.001, respectively).  
The ROC analysis of wall thickness for the diagnosis of PVE beyond three 
months postoperatively showed an area under the curve of 0.89 (95% CI 0.81–
0.96) (Fig. 17). With a cutoff value of 5 mm, the sensitivity was 67%, the speci-
ficity was 95%, the positive likelihood ratio was 14.1, and the negative likeli-
hood ratio was 0.35. 
 
 
 
  
 
Figure 17. ROC curve of the performance of aortic wall thickness in the diagnosis of PVE. The asterisk 
marks the coordinate for a 5 mm cutoff. 
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Paper III 
Eight 18F-FDG PET/CT examinations in patients with suspected PVE were com-
pared to 19 18F-FDG PET/CT examinations in control patients without PVE. On 
visual analysis, the sensitivity was 75%, the specificity was 84 %, the positive 
likelihood ratio was 4.8 and the negative likelihood ratio was 0.3 for the detec-
tion of PVE. Prosthetic valve SUVmax was significantly higher in PVE patients 
[5.8 (IQR 3.5–6.5)] than in non-PVE patients [3.2 (IQR 2.8–3.8)] (p < 0.001) 
(Fig. 18A). The prosthetic valve to background SUVratio was also significantly 
higher in PVE patients [2.4 (IQR 1.7–3.0)] compared to non-PVE patients [1.5 
(IQR 1.3–1.6)] (p < 0.001) (Fig. 18B). 
 ROC analysis of prosthetic valve SUVmax and SUVratio for the diagnosis of 
PVE yielded an area under the curve of 0.90 (95% CI 0.77–1.0) and 0.90 (95 % 
CI 0.74–1.0), respectively (Fig. 19). 
 
 
 
 
 
Figure 18. Boxplot of SUVmax (A) and SUVratio (B) in non-PVE and PVE cases. Both SUVmax and SUVratio 
were significantly higher in PVE cases.  	  
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Figure 19. ROC curves for the performance of SUVmax and SUVratio in the diagnosis of PVE. 
 
 
 
Paper IV 
Sixty-eight PVE cases that had undergone both ECG-gated CT and TEE were 
included in the study. In total, 58 out of 68 patients had indications for surgery. 
The numbers of cases with indications for surgery based on CT and TEE find-
ings are shown in Fig. 20. In eight cases (14%), there was indication for surgery 
based on CT but not on TEE findings, and in all of these cases CT detected 
pseudoaneurysms that were not seen with TEE. On the other hand, there were 11 
cases (19%) where there was indication for surgery based on TEE but not on CT 
findings (large vegetation n = 1; valve destruction n = 1, valve dehiscence n = 4; 
non-drained abscess n = 5).  
 Of 36 patients who underwent surgery, 32 had indications for preoperative 
coronary angiography according to guidelines [33]. In 31 out of these 32 pa-
tients, ECG-gated CT coronary angiography was diagnostic. In one patient, 
ECG-gated CT coronary angiography was inconclusive, and invasive coronary 
angiography was performed. 
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Figure 20. Indication for surgery based on imaging findings in 68 PVE cases. 
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Discussion 
PVE is a disease with high mortality and it is important that the diagnosis is 
made as soon as possible because initiation of therapy (antibiotics and in many 
cases surgery) is crucial for the prognosis [11]. The diagnosis of PVE is based 
on the modified Duke criteria, where positive blood cultures and imaging find-
ings are the two major criteria [55]. Imaging is routinely performed with TTE 
and TEE. TEE is the recommended imaging method in the presence of a pros-
thetic valve and it has higher sensitivity than TTE [11]. However, both methods 
have diagnostic shortcomings. TTE has been reported to be positive in only 15–
36% of PVE patients and TEE in 80–86% [18-20]. These diagnostic difficulties 
suggest the need for additional imaging modalities to improve the diagnostic 
workup of PVE patients. By adding information from new imaging modalities, 
more patients with PVE might be detected and the diagnosis can be made earlier 
and with a higher degree of reliability. Early diagnosis may improve the progno-
sis [56].  
Imaging in PVE patients is also used to determine the extension of infection, 
which influences the decision of therapy (conservative/surgical) [17]. The identi-
fication of patients in need of surgery is important because surgery improves the 
prognosis [112]. The timing of surgery can also influence the outcome, and early 
surgery is preferred in patients with complicated endocarditis [113]. Local un-
controlled infection, defined as extension of infection into the perivalvular tissue 
with perivalvular abscess cavities, pseudoaneurysms, and/or prosthetic valve 
dehiscence, is an indication for surgery [17]. In a study comparing TEE findings 
with surgery, abscess formation was missed by TEE in 36% of PVE cases, and 
prosthetic valve dehiscence was missed in 29% [114]. Hence, there is a need for 
other imaging modalities also to determine the extension of infection, which may 
influence surgical decision-making.  
ECG-gated CT in the diagnosis of PVE 
The results from paper I indicate that ECG-gated CT is comparable to TEE in 
the diagnostic performance of patients with PVE. ECG-gated CT detected signs 
of PVE in 25 out of 27 patients, whereas TEE was positive in all 27 patients. 
This result is consistent with that in a study by Feuchtner et al where CT was 
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positive in 28 out of 29 endocarditis patients with positive TEE (a majority of 
the valves were native) [93]. However, our results suggested that the profiles of 
the two imaging methods might be different and complementary:  
1) TEE detected more vegetations than CT. Small vegetations have also been 
reported to be missed by CT in studies by Feuchtner and Gahide et al, where a 
majority of the valves were native [93,115]. This fact is likely to be related to the 
higher temporal resolution of TEE compared to CT.  Because the valves move 
rapidly when opening and closing, TEE has a greater ability to depict small mov-
ing vegetations that might be blurred on CT images with lower temporal resolu-
tion.  
2) TEE was superior to CT in detecting signs of valve dehiscence. Previous re-
ports on CT and valve dehiscence are scarce. The study by Feuchtner et al had 
only one case of valve dehiscence, and this was detected by both CT and TEE 
[93]. In a study by Pizzi et al, which only included PVE patients, CT detected 
four out of eight cases of valve dehiscence [116]. TEE has the advantage over 
CT in that Doppler imaging can be used to detect perivalvular blood flow as a 
sign of dehiscence [117]. In our experience, CT can show a rocking motion of 
the prosthesis during the cardiac cycle in cases of a large dehiscence, but it has 
difficulties in detecting small perivalvular leaks.  
3) CT detected more pseudoaneurysms than TEE. This finding is in accordance 
with the study by Feuchtner et al where most valves were native and with a study 
by Habets et al on prosthetic heart valves [93,118]. CT provides good image 
quality around the entire circumference of the prosthetic valve. With TEE, how-
ever, echo shadowing from the valve prosthesis is a problem, and certain parts of 
the circumference might be obscured. Because the right coronary cusp is posi-
tioned opposite to the TEE transducer, this region is most commonly affected by 
echo shadowing [119]. This fact is supported by findings in paper IV where six 
of 11 pseudoaneurysms detected with CT but not TEE were positioned adjacent 
to the right coronary cusp.  
In addition to the imaging signs described above that are all included in the 
diagnostic criteria of PVE, we studied the thickness of the aortic root wall. In-
creased aortic root wall thickness on TEE as a sign of PVE has been described in 
some previous publications [114,120] and is used in our clinical practice with 
TEE. However, no studies have been published that evaluate the accuracy of this 
sign. We and others have hypothesized that abscess formation, which is a dy-
namic process, starts with inflammation that leads to increased wall thickness in 
the aortic root [17]. We included this sign of PVE in paper I and found that in-
creased wall thickness was a common finding in PVE patients both on CT and 
TEE. This led to the hypothesis that increased aortic wall thickness can be used 
as a sign of PVE on CT, and this hypothesis was tested in paper II.  
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In paper II, we showed that an aortic root wall thickness >5 mm is a highly 
specific sign of PVE (specificity 95%). However, the sensitivity of the sign was 
lower (67%). A possible reason for this is that increased wall thickness repre-
sents invasion of bacteria into the aortic wall with inflammation in the tissue, but 
this pathological process is not present in all PVE patients. A subgroup of pa-
tients has an infection limited to the valve leaflets with valve vegetations and/or 
destruction as the only imaging manifestations of infection [17], and this group 
of patients might have a normal wall thickness in the aortic root.  
Interestingly, six patients in paper IV had non-drained abscess cavities that 
were detected with TEE but not with CT. In all six cases, the wall thickness was 
increased in the same region on CT. This finding suggests that focal increased 
wall thickness on CT might represent a non-drained abscess cavity. This is in 
accordance with findings from Habets et al, who reported that in three cases of 
abscesses detected with TEE but not with CT, nonspecific aortic wall thickening 
was present on CT when images were retrospectively evaluated [118]. However, 
increased wall thickness can be seen on TEE in the absence of visible abscess 
cavities, and it is likely that increased wall thickness can also be an early sign of 
extension of infection into the perivalvular tissue that precedes the formation of 
an abscess cavity. In paper III, we describe a case with focal increased wall 
thickness of the aortic wall on CT and vegetations on TEE as the only imaging 
findings. 18F-FDG PET/CT showed increased 18F-FDG uptake in the region of 
increased wall thickness, and surgery confirmed abscess formation in this region.  
In summary, increased wall thickness of the aortic root on CT is a specific 
sign of PVE and might be the first sign of extension of infection into the aortic 
wall. Adding increased wall thickness as a diagnostic criterion of PVE might 
improve the performance of the modified Duke criteria.  
18F-FDG PET/CT in the diagnosis of PVE 
The concept of using 18F-FDG PET/CT in the diagnosis of PVE is appealing 
because it has the potential to depict the actual inflammatory activity caused by 
the infection. This is in contrast to ECG-gated CT and TEE, both of which are 
purely morphological methods. The first report on PET and endocarditis con-
cerned native valves, and the results were discouraging with a reported sensitivi-
ty of 39% and a specificity of 93% for the diagnosis of endocarditis [108]. A 
possible reason for the low sensitivity is that vegetation is the most common 
imaging finding in NVE [46]. Because of the fast movement of the valve leaflets 
and adherent vegetations, they can be difficult to depict with 18F-FDG PET/CT, 
which has low temporal resolution and is routinely performed without ECG-
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gating. In paper III, we studied the diagnostic performance of 18F-FDG PET/CT 
in the diagnosis of PVE and found a higher sensitivity (78%). Our result is simi-
lar to four other studies published on 18F-FDG PET/CT and PVE showing a sen-
sitivity of 73%, 93%, 89%, and 87%, respectively [109,116,121,122]. The higher 
sensitivity in PVE compared to NVE is likely to be due to the higher presence of 
perivalvular extension of infection in PVE. The perivalvular tissue is not moving 
to the same extent as the valve, which means that high temporal resolution is less 
important.  
The main contribution of paper III is that we, in contrast to previous studies, 
included a control group containing patients without suspicion of PVE. Previous 
studies were performed on patients with a high suspicion of PVE without nega-
tive controls, and the risk of false positive results was a concern [123]. We 
showed that 18F-FDG uptake around non-infected aortic prosthetic valves was 
low. The specificity of 18F-FDG PET/CT was 84% with visual analysis, which is 
similar to the specificity presented in previous studies (80%, 71%, and 92%) 
[109,116,121]. Our results also showed that semi-quantitative analysis of 18F-
FDG-uptake by measuring the SUVratio had good accuracy for the diagnosis of 
PVE (ROC analysis gave an area under the curve of 0.90). It is likely that the 
specificity of the method can be further improved by combining visual analysis 
and measurement of the SUVratio. For evaluation of cutoff values, further studies 
are needed.  
ECG-gated CT and 18F-FDG PET/CT in surgical deci-
sion-making 
In paper IV, we studied the role of ECG-gated CT in surgical decision-making. 
Surgical decision-making in PVE patients is a complicated process that is influ-
enced by both the extension and activity of the infection, the response to treat-
ment with antibiotics, complications, the clinical status of the patient, and 
comorbidities [124]. Current guidelines emphasize that decision-making should 
be managed by a dedicated endocarditis team [17]. Imaging in the evaluation for 
surgery is routinely performed with TEE, and the following imaging findings are 
considered indications for surgery: abscess/pseudoaneurysm formation, valve 
dehiscence, large vegetations, and valve leaflet destruction [11]. In paper IV, we 
found that out of 58 PVE cases with indication for surgery based on imaging 
findings, 14% had indication for surgery based on CT but not TEE findings and 
19% had indication for surgery based on TEE but not CT findings. The strength 
of CT was that it was superior to TEE in detecting perivalvular pseudoaneu-
rysms as a sign of perivalvular extension of infection. This is in accordance with 
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previously published data from Habets et al who studied 28 PVE patients and 
found that CT resulted in a major diagnostic change in 21% of patients, mainly 
driven by novel detection of pseudoaneurysms by CT [118]. Our results empha-
size the need for both ECG-gated CT and TEE in the preoperative evaluation 
because both examinations add important information.  
Another advantage of ECG-gated CT in the preoperative evaluation is that it 
includes evaluation of the coronary arteries. Preoperative coronary angiography 
is recommended according to guidelines in men >40 years, post-menopausal 
women, and patients with at least one cardiovascular risk factor or a history of 
coronary artery disease [33]. In PVE patients, it is considered safe to perform 
coronary angiography unless there are large vegetations that might dislodge from 
the valve during the procedure [125]. However, coronary angiography is an in-
vasive procedure with a reported overall complication rate of 2–4% and a mor-
tality rate of 0.1% [126,127]. Bettencourt et al reported that invasive coronary 
angiography could be replaced by ECG-gated CT in 73% of patients planned for 
valve surgery, and Catalan et al found that ECG-gated CT was diagnostic in 81% 
of patients scheduled to undergo non-coronary cardiac surgery [128,129]. In 
paper IV, ECG-gated CT could replace invasive coronary angiography in 31 out 
of 32 patients (97%). A possible reason for the higher proportion of diagnostic 
examinations in our study is that only the nine most proximal coronary artery 
segments were included in the analysis, which is in contrast to the other two 
studies that included all 17 coronary artery segments. The reason for including 
only the proximal segments was that these are the segments that can be consid-
ered for bypass grafting during the surgical procedure.  
Another advantage of ECG-gated CT in the preoperative evaluation is that it 
provides information regarding anatomy, including the course of bypass grafts in 
relation to the sternum and anatomical anomalies of the native coronary arteries. 
This information helps the surgeon to minimize the risk during surgery, and pre-
ventive surgical strategies can be adopted in high-risk patients [130]. Performing 
CT as part of the preoperative evaluation has been shown to reduce the risks 
associated with re-do cardiac surgery [131]. 
The usefulness of 18F-FDG PET/CT in surgical decision-making has to our 
knowledge not been studied. Paper III focused on the diagnostic ability of 18F-
FDG PET/CT in the diagnosis of PVE but we did not study how 18F-FDG 
PET/CT influenced surgical decision-making. Interestingly, in this retrospective 
study, 5 out of 11 18F-FDG PET/CT studies on PVE patients were performed 
when results from routine clinical workup were inconclusive regarding the ex-
tension of the infection. Because 18F-FDG-uptake around the prosthetic valve 
represents inflammatory activity, it is possible that high 18F-FDG uptake repre-
sents a more active infection, which could support the need for surgery. Further 
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studies are needed to evaluate if 18F-FDG uptake in the perivalvular area can be 
used as an indication for surgery.  
Diagnosis of PVE in the early postoperative period 
The diagnosis of PVE is particularly challenging in the early postoperative peri-
od when the clinical presentation might be atypical, and fever and inflammatory 
syndrome can also be seen in the absence of infection [47]. TEE findings can be 
difficult to interpret, and the diagnosis of an abscess is more difficult in this pe-
riod [117]. Edema and inflammation in the perivalvular area is a part of the heal-
ing process after surgery and cannot easily be distinguished from infection 
[117,132]. In paper II, increased wall thickness of the aortic root was a common 
finding during the first months postoperatively in non-PVE patients, and we 
suggest that this sign should be used only beyond three months postoperatively.   
18F-FDG PET/CT can also be false positive in the early postoperative period. 
In a study by Rouzet et al, false positive 18F-FDG PET/CT was seen in six out of 
39 patients with suspected PVE, and all six patients had been investigated during 
the first two months postoperatively [121]. In paper III, only one 18F-FDG 
PET/CT examination in a non-PVE patient was performed in the early postoper-
ative period, and this was correctly interpreted as negative. The time limit after 
which 18F-FDG PET/CT can be considered safe to use in the diagnosis of PVE 
has not yet been studied. It is possible that a higher cutoff value for SUVratio can 
be used to compensate for the expected higher inflammatory activity in the early 
postoperative period. In the study by Rouzet et al, leukocyte single-photon emis-
sion computed tomography (SPECT) had higher specificity than 18F-FDG 
PET/CT for the diagnosis of PVE in the early postoperative period, and this 
method might be of value in unclear cases [121]. 
Limitations 
The major limitation of paper I and IV is that surgery, which could be considered 
the gold standard for confirmation of imaging findings, was not performed in all 
patients. The major limitation of paper II and III is the retrospective study design 
with PVE groups and control groups that were different in some respects. In pa-
per II, the control group consisted of CT examinations performed on different 
scanners, and the majority of the examinations were not ECG-gated. In paper III, 
the control group consisted of 18F-FDG PET/CT examinations performed on 
cancer patients with a different clinical background from the PVE patients. An-
other limitation is the small study populations in papers I and III.  
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General discussion on imaging of PVE patients 
Both ECG-gated CT and 18F-FDG PET/CT are imaging methods that add infor-
mation to TEE in the workup of patients with suspected PVE and might be valu-
able complements. Besides the diagnostic value of an imaging method, 
availability, costs, and risks are factors to consider. Echocardiography is widely 
available, safe, and performed at low cost. The availability of ECG-gated CT is 
increasing, and it is likely to be available in most hospitals in Sweden within a 
few years. In addition, the radiation dose of ECG-gated CT is getting lower with 
modern equipment. The risk of contrast-induced nephropathy is a concern, but 
with the use of a low-kilovoltage protocol, the contrast dose can be minimized in 
patients with impaired renal function. Nevertheless, potential damage of the kid-
neys is a possibility. 18F-FDG PET/CT is the most expensive examination of the 
three and also has a limited availability. The method is time consuming and re-
quires a special diet.  
The workup of patients with suspected PVE should include both TEE and 
ECG-gated CT. ECG-gated CT is less operator-dependent than TEE and can be 
performed at the local hospital with the images being sent to a tertiary center for 
evaluation. ECG-gated CT can facilitate early diagnosis when TEE results are 
equivocal, and it provides information that can influence surgical decision-
making. 18F-FDG PET/CT is a valuable tool when the diagnosis remains unclear 
after TEE and ECG-gated CT have been performed. The method might also add 
information regarding extension and activity of the infection. However, the value 
of 18F-FDG PET/CT in surgical decision-making has not yet been studied. In the 
early postoperative period, imaging findings must be interpreted with caution, 
and repeated TEE/ECG-gated CT examinations might be valuable for studying 
the evolvement of findings over time. 
  In Gothenburg, information from ECG-gated CT performed in the prospec-
tive study during 2008–2015 (paper I and IV) was used when the endocarditis 
team evaluated the patients, and the method is now part of the routine clinical 
workup of PVE patients. If CT detects signs of perivalvular extension of infec-
tion and TEE is negative or inconclusive, the patient is considered to have a local 
uncontrolled infection and is evaluated for surgery. From 2013 onwards, 18F-
FDG PET/CT has been used when results from TEE and ECG-gated CT are in-
conclusive regarding the diagnosis or extension of infection (paper III). The Eu-
ropean Society of Cardiology (ESC) confirms that this diagnostic strategy is 
appropriate in the updated guidelines for the management of IE published in 
2015 [17]. In the ESC guidelines, a modification of the diagnostic criteria is 
suggested where two imaging findings have been added as major criteria in the 
diagnosis of endocarditis: 
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1. Based in part on results from paper I, where ECG-gated CT was shown to 
have comparable diagnostic performance to TEE in the diagnosis of PVE, one 
new major criterion is the detection of paravalvular lesions by cardiac CT. 
2. In patients with a prosthetic valve, abnormal activity around the site of im-
plantation detected by 18F-FDG PET/CT (if the prosthesis has been present for 
>3 months) or radiolabelled leukocyte SPECT/CT is now considered a major 
criterion [17]. 
A diagnostic algorithm is proposed in the guidelines where both cardiac CT and 
18F-FDG PET/CT can be used as second-line imaging when the initial evaluation 
with echocardiography shows no definite PVE according to the Duke criteria but 
high suspicion of endocarditis remains [17].  
In 2015, the American Heart Association also published updated guidelines 
for the management of IE [133]. These guidelines have a more conservative ap-
proach and do not support the inclusion of imaging criteria from modalities other 
than echocardiography in the diagnostic workup [133]. Because both ECG-gated 
CT and 18F-FDG PET/CT are relatively new imaging methods, the optimal use 
in the workup of PVE patients remains to be shown.  
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Conclusions 
• ECG-gated CT has comparable diagnostic performance to TEE in pa-
tients with aortic PVE. 
 
• Increased aortic wall thickness (> 5mm) beyond three months postoper-
atively significantly increases the likelihood of PVE. 
 
 
• The level of 18F-FDG uptake in the prosthetic valve area shows good 
diagnostic performance in the diagnosis of PVE. The 18F-FDG uptake 
around non-infected aortic prosthetic valves is low. 
 
• ECG-gated CT provides additional information over TEE regarding 
perivalvular extension of infection, which can influence surgical deci-
sion-making. ECG-gated CT provides a non-invasive coronary angio-
gram and can in most cases replace invasive coronary angiography in 
the preoperative evaluation. 
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Future Perspectives 
Cardiac magnetic resonance imaging (MRI) is used for evaluating valve dys-
function and quantifying valve stenosis and regurgitation [134]. Cardiac MRI is 
considered safe with most available valve prostheses [135]. However, cardiac 
MRI is not currently used in the diagnosis of endocarditis. Case reports have 
described the detection of vegetations [136-138], paravalvular abscess [139], and 
pseudoaneurysm [140] in patients with aortic and mitral valve endocarditis. Re-
cently a small study showed that MRI might be of use in patients with endocar-
ditis [141], but no larger studies have been performed. A possible advantage of 
MRI compared to CT is that MRI is superior in tissue characterization, and it has 
the potential to detect edema and contrast enhancement in the aortic root as signs 
of infection. The temporal resolution is also higher with MRI than with CT, 
which might be of importance in the detection of mobile vegetations. Further-
more, MRI can quantify a valvular/paravalvular leak with velocity-encoded 
phase-contrast imaging. It is possible that a paravalvular leak can be character-
ized with 4D flow imaging, a new technique that can describe complex flow 
patterns and that does not require breath-holding [142]. Disadvantages of MRI 
are that most sequences require repeated breath holds and that it is a relatively 
long procedure, which can be difficult for ill patients. Another problem is arti-
facts from the metal in mechanical prosthetic valves, which probably makes the 
method less useful in these patients. Development of methods for metal artifact 
reduction might overcome this problem in the future.  
Leukocyte SPECT/CT is a nuclear medicine imaging method that has been 
used in PVE patients [143]. With this method, the patient’s own white blood 
cells are labeled with 99mTc and the SPECT scanner detects the distribution of 
white blood cells in the body. A site of infection means accumulation of white 
blood cells, and the method has shown high specificity in the diagnosis of PVE 
[143]. However, the method is time-consuming and expensive because the pa-
tient’s white blood cells need to be collected beforehand. The method might 
have a value in the early postoperative period where 18F-FDG PET/CT can be 
false positive due to postoperative inflammation [121]. 
Three-dimensional TEE provides 3D-images of the aortic valve, and a small 
publication has suggested that the method might have additional value compared 
to 2D TEE in the diagnosis of PVE [144]. Larger comparative studies are needed 
  
Future Perspectives 55	
to determine whether this method can improve the diagnostic performance of 
TEE. 
The technique of ECG-gated CT might be further refined by the use of dual 
energy. Dual energy means that two CT datasets are acquired with the use of 
different tube potentials [145]. The technique generates a virtual non-contrast 
dataset that can replace the unenhanced acquisition and thus might lower the 
radiation dose [146]. Low-energy images improve the detection of iodine and 
could make it easier to detect contrast enhancement in the aortic wall and sur-
rounding soft tissue as a sign of infection.   
The temporal resolution of the 18F-FDG PET/CT examination can be im-
proved with ECG-gating of the PET acquisition, and this is a method that is al-
ready in use and might facilitate the detection of activity around the prosthetic 
valve [116]. This scan can be combined with ECG-gated CT in the same imag-
ing session to provide both high-resolution morphological images and infor-
mation about activity [116].  
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Sammanfattning på svenska 
Protesendokardit (PVE) är en infektion på och/eller runt en inopererad klaff-
protes, vilket är ett tillstånd med hög dödlighet. Antibiotika används som behan-
dling men i många fall behövs också kirurgi. Diagnosen är svår att ställa och den 
undersökningsmetod som rutinmässigt används är transesofagealt ultraljud 
(TEE; ultraljud via matstrupen). Fynden kan vara svårtolkade vid PVE och en 
del fall undgår korrekt diagnos. Det finns därför behov av kompletterande un-
dersökningsmetoder för att förbättra diagnostiken.  
 I avhandlingen har två nya undersökningsmetoder som har potential att 
användas vid diagnostik av PVE i aortaklaffen studerats. Elektrokardiografi-
styrd datortomografi (EKG-styrd CT) ger högupplösta skiktröntgenbilder av 
hjärtat. 18F-fluorodeoxyglukos positron emission tomografi/datortomografi (18F-
FDG PET/CT) avbildar sockerkonsumtionen i kroppens vävnader med hjälp av 
en radioaktiv isotop i kombination med skiktröntgen. Metoden används hu-
vudsakligen i cancerdiagnostik men lokalt ökad sockerkonsumtion kan också ses 
vid infektion.  
 I delarbete I och IV undersöktes patienter med PVE i aortaklaffen med TEE 
och EKG-styrd CT (2008-2015). De två undersökningsmetoderna hade olika 
styrkor. TEE påvisade i fler fall bakeriepålagringar (vegetationer) på klaffbladen 
samt tecken på att klaffprotesen lossnat. EKG-styrd CT gav säkrare information 
om tjockleksökning i aortarotens vägg och tömda varhärdar kring klaffprotesen, 
vilka utgör tecken på att infektionen spridit sig från klaffen in i kärlväggen. Om 
man använde sig av båda metoderna i utredningen av patienter med PVE kunde 
fler fall med behov av kirurgi identifieras än om endast den ena metoden anvä-
ndes. EKG-styrd CT avbildar även kranskärlen och kunde i de flesta fall ersätta 
traditionell kranskärlsröntgen i utredningen inför operation.  
I delarbete II studerades väggtjockleken i aortaroten hos personer som opererats 
med klaffprotes i aorta. Väggtjockleken var ökad direkt efter operationen som en 
följd av det kirurgiska ingreppet. Efter tre månader hade väggtjockleken normal-
iserats. Patienter med PVE hade i de flesta fall ökad väggtjocklek i aortaroten 
som tecken på att infektionen engagerat kärlväggen. En väggtjocklek >5 mm 
(senare än tre månader efter operation) var ett känsligt och användbart tecken på 
PVE.  
 I delarbete III jämfördes 18F-FDG PET/CT hos personer med klaffprotes med 
och utan PVE. 18F-FDG-upptaget var lågt kring klaffprotesen hos personer utan 
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PVE. Patienter med PVE hade ett förhöjt 18F-FDG-upptag och upptagsnivån var 
användbar i diagnostiken av PVE.  
 Sammanfattningsvis kan både EKG-styrd CT och 18F-FDG PET/CT vara 
komplement till TEE och öka säkerheten i diagnostiken av PVE.  
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